Carta Healthcare®, a company dedicated to leveraging clinical data to enhance patient care, has announced the successful completion of its series B financing with an additional $25 million in funding. Memorial Hermann Health System and UnityPoint Health are among the notable investors joining the round.
This additional investment follows the initial series B financing of $20 million, which was announced in November 2022 and attracted participation from investors such as Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures.
Matt Hollingsworth, co-founder and CEO of Carta Healthcare, expressed enthusiasm for the visionary and forward-thinking investors who share the company’s commitment to accelerating the development of healthcare technologies. The new funding will enable Carta Healthcare to scale its operations and further advance product development, ultimately making their solutions more accessible to a wider range of health systems.
Carta Healthcare is a leading provider of clinical data collection, analysis, and insights. With cutting-edge technology and a team of experienced clinicians, the company delivers top-quality registry data abstraction, reporting, and analytics to prominent healthcare systems across the nation. By streamlining the abstraction process and offering powerful analytical capabilities, Carta Healthcare empowers data-driven decision-making, leading to improved patient outcomes, cost savings in data processing, and enabling healthcare professionals to focus more on patient care instead of tedious data entry.
Memorial Hermann Health System sees investments in solutions that align with their vision of creating healthier communities. Feby Abraham, Executive Vice President, and Chief Strategy Officer for Memorial Hermann, emphasized how Carta’s platform provides providers and researchers with timely, actionable analytics and insights that can drive significant improvements in quality and enhance research capabilities.
According to Matt Warrens, Managing Director of UnityPoint Ventures, the healthcare industry is at a critical juncture where automation plays a pivotal role. Warrens highlighted that automation in healthcare is not about bridging the gap between the need for clinicians, but rather equipping healthcare professionals with tools that enable them to provide high-quality care more efficiently.
Carta Healthcare’s latest funding round demonstrates strong support for their mission to transform healthcare through the effective use of clinical data. The investment will fuel the company’s growth, allowing them to continue making significant contributions to the industry’s advancement and the improvement of patient care.
